NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

KMTS

Kestra Medical Technologies Ltd

May 15 • 04:00PM ET

23.75

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Held by: VTI FMED VXF ONEQ VTWO VTWG VTWV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.90	Insider Own	60.77%	Shs Outstand	51.35M	Perf Week	4.95%
Market Cap	1.22B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	20.14M	Perf Month	-1.57%
Income	-95.07M	PEG	-	EPS next Q	-0.53	Inst Own	16.40%	Short Float	4.72%	Perf Quarter	-
Sales	52.64M	P/S	23.17	EPS this Y	-	Inst Trans	-78.04%	Short Ratio	3.34	Perf Half Y	-
Book/sh	-5.34	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.95M	Perf Year	-
Cash/sh	1.06	P/C	22.44	EPS next 5Y	-	ROE	-	52W Range	20.00 - 26.15	Perf YTD	8.75%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-179.15%	52W High	-9.18%	Beta	-
Dividend TTM	-	Quick Ratio	1.65	Sales past 5Y	264.53%	Gross Margin	37.73%	52W Low	18.75%	ATR (14)	1.56
Dividend Ex-Date	-	Current Ratio	1.81	EPS Y/Y TTM	-	Oper. Margin	-149.17%	RSI (14)	52.43	Volatility	5.16% 6.28%
Employees	-	Debt/Eq	7.22	Sales Y/Y TTM	-	Profit Margin	-180.62%	Recom	1.33	Target Price	27.50
Option/Short	No / Yes	LT Debt/Eq	7.22	EPS Q/Q	-2.24%	Payout	-	Rel Volume	0.00	Prev Close	23.75
Sales Surprise	0.12%	EPS Surprise	-107.19%	Sales Q/Q	82.31%	Earnings	Apr 14 AMC	Avg Volume	284.55K	Price	23.75
SMA20	0.93%	SMA50	1.39%	SMA200	1.39%	Trades		Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-31-25	Initiated	Wolfe Research	Outperform	$29
Mar-31-25	Initiated	Wells Fargo	Overweight	$28
Mar-31-25	Initiated	Stifel	Buy	$28
Mar-31-25	Initiated	Piper Sandler	Overweight	$27
Mar-31-25	Initiated	Goldman	Neutral	$24
Mar-31-25	Initiated	BofA Securities	Buy	$30

May-13-25 08:00AM	Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year 2025 Mountain West Award Finalist (GlobeNewswire)
Apr-30-25 08:00AM	Kestra Medical Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-29-25 08:00AM	Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025 (GlobeNewswire)
Apr-23-25 08:00AM	Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025 (GlobeNewswire)
Apr-14-25 04:01PM	Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire)
04:05PM	Loading…
Apr-02-25 04:05PM	Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14 (GlobeNewswire) -6.54%
Mar-14-25 04:05PM	Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering (GlobeNewswire) +16.50%
Mar-07-25 05:30PM	Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering (GlobeNewswire)
Mar-05-25 11:03PM	Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)
Feb-26-25 08:00AM	Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering (GlobeNewswire)

Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company was founded by Brian Webster and Phillip D. Foshee in 2014 and is headquartered in Kirkland, WA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

KMTS

Kestra Medical Technologies Ltd

Upgrade your FINVIZ experience